Aktis Oncology (AKTS) Stock Chart
NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 2:35 PM ET
AKTS technical summary
AKTS is trading 23.2% below its 50-day simple moving average of $23.05. The 14-day Relative Strength Index (RSI) is 25.4, below 30, the level many traders consider oversold. Over the past year, the stock ranged from $14.72 (Mar 30, 2026) to $34.19 (Jun 30, 2026); the current price sits 15% of the way from the low to the high.
Annualized 30-day volatility is 48.9%. Based on the last session's high, low and close, the classic pivot point is $18.02, with first resistance at $18.33 and first support at $17.70. These indicators describe past price behavior for Aktis Oncology; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
Technical indicators
- RSI (14)
- 25.4
- 50-day SMA
- 23.05
- Beta
- —
- 1Y high
- 34.19 (Jun 30)
- 1Y low
- 14.72 (Mar 30)
- Last close
- 17.71
AKTS price performance
1 week
-7.55%
1 month
-28.06%
3 months
-37.26%
6 months
+6.01%
AKTS price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 18.28Price below | 18.36Price below |
| 10-day | 18.90Price below | 19.07Price below |
| 20-day | 20.63Price below | 20.41Price below |
| 50-day | 23.05Price below | 22.24Price below |
| 100-day | 23.36Price below | 22.51Price below |
Moving averages are computed from daily closing prices over the past year. What is a moving average?
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 18.96 |
| Resistance 2 (R2) | 18.65 |
| Resistance 1 (R1) | 18.33 |
| Pivot point | 18.02 |
| Support 1 (S1) | 17.70 |
| Support 2 (S2) | 17.39 |
| Support 3 (S3) | 17.07 |
Classic floor-trader pivots from the last session's high, low and close. How pivot points work